Skip to content

the effect on intestinal microbiota with iron-based phosphate binder

the effect on intestinal microbiota with iron-based phosphate binder - the effect on intestinal microbiota with iron-based phosphate binder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026666
Enrollment
72
Registered
2017-03-23
Start date
2016-05-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic renal failure

Interventions

None listed

Sponsors

Saiseikai Niigata Daini Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: hyperphosphatemic patients on hemodialysis with ferric citrate hydrate, Sucroferric oxyhydroxide, and normophosphatemic patients on hemodialysis without phosphate binder

Exclusion criteria

Exclusion criteria: patients with anti-biotic agents which influenced intestinal microbiota

Design outcomes

Primary

MeasureTime frame
analysis of intestinal microbiota of hemodialysis patients with ferric citrate hydrate, Sucroferric oxyhydroxide, and no-phosphate binder

Countries

Japan

Contacts

Public ContactAkira Iguchi

Nagaoka red cross hospital Division of ClinicaNephrology and Rheumatology

igucci4444@yahoo.co.jp0258-28-3600

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026